Company Data

Sage Therapeutics Inc.

Ticker
SAGE
Current Price
$7.31 2.24%
Market Cap
$449.4M
Price Target
Refer to Report
Volume
1.9M
52wk Range
$4.62 - $23.22
Advanced Market Data

Overview

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the study of the nervous system and brain to discover medicines to treat life-threatening, rare central nervous system disorders. The company’s lead development program is SAGE-217 program which is in Phase 3 clinical trials for post-partum depression, essential tremor, Parkinson’s disease, and major depressive disorder. The company is also developing several other compounds for treatment that are in the early stage of development.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy